Affiliation: National Institute for Biological Standards and Control (NIBSC)/Medicines and Healthcare products Regulatory Authority (MHRA)

Carmen Coxon is a senior scientist with specialist knowledge in the area of thrombosis and haemostasis. Having completed a PhD in cardiac regeneration at the University of Reading in 2006 she worked in academia for ten years at the universities of Oxford and Bristol on target and drug discovery, with an emphasis on novel antiplatelets and Ig superfamily receptors. She moved to the National Institute for Biological Standards and Control in 2017 where she worked as a research fellow on the development of biological standards for clinical tests in the area of rare bleeding disorders, as well as working with colleagues and collaborators to investigate the effect of reduction/oxidation on clinically relevant biomolecules.